There are different end points. Here is the PR from Oct 2012. http://newsroom.athersys.com/news/athersys-reports-on-progress-in-phase-2-study-of-multistem-for-ischemic-stroke I know we should hear something within 90 days of completion. They will, as you say, watch them a long time. I still think this company moves at a snails pace. It is tough waiting. All the time. THey have listed many things for this year. Want to see what of those things get completed.
Investing in these bio techs and Patent Companies is tiresome....
News 
Market Data 
Discover 
